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Evaluating the relationship and outcomes of ischemic stroke in patients with COVID-19. While also reviewing
overall incidence and mortality of stroke in vulnerable populations in the US.
Jaime Dougherty OMS-II

Results

Background
• COVID-19 has affected the worldwide population
since early 2020 and has remained a health issue
since. Among the various symptoms and
outcomes people are encountering when
infected with COVID, this virus has also been
connected to severe vascular insults involving
large vessel occlusions.

• Current stroke statistics indicate a nearly twice
as high risk of stroke in African Americans when
compared to whites6.
• This brings into question how social
determinants of health are affecting COVID-19
and stroke incidence.
• The purpose of this review is to investigate the
relationship between COVID-19 and ischemic
stroke while advocating for a more robust
primary prevention approach of stroke in
vulnerable populations1-3.

Discussion

COVID pathophysiology includes utilization of
angiotensin converting enzyme 2 (ACE2) to enter cells
where downstream effects include thrombosis,
microangiopathy, endothelial activation and
angiogenesis 4,5.

A multistate analysis which included 417 hospitalized
adults 65 years of age and older, was performed to
evaluate vaccine effectiveness in reducing disease
severity. Effectiveness was shown to be 94% for full
vaccination with either the Moderna or Pfizer vaccine.
This data continues to highlight the importance of
vaccination in high-risk populations including those
affected by COVID-19 with ischemic stroke as a severe
outcome. 7

The underlying physiological damage inflicted by the
COVD-19 virus includes a cytokine storm which ensues
continued endothelial damage. Widespread severe
inflammation allows for fibrin clot formation, micro
thrombus, DIC, and multi organ failure. 4,5

Conclusion

Methods
From September 2021 to November 2021, I searched
the following databases: PubMed, CDC, NIH, National
Stroke Association, New England Journal of Medicine,
to investigate research studies related to COVID’s
pathophysiology, the relationship between COVID and
the incidence of large vessel occlusions, minority
populations and the effect COVID has had on them, the
various vaccines available for COVID, and lifestyle
changes to reduce the risk of stroke.

• The findings from the literature review aids physicians in
recognizing the importance of management of COVID-19
patients with the possibility of developing a large vessel
occlusion
Economic and social disparities, unequal access to
healthcare, and genetic factors which have been
linked to a more severe inflammatory response and
are seen in Latinos and African Americans. 8

Types of studies. I included studies that evaluated metaanalyses, case reports, clinical trials, retrospective and
prospective chart reviews, or efficacy-based models.
Qualitative methods and mixed method evaluations
were conducted throughout studies included.

In 2019, a Global COVID-19 Stoke registry was created
amongst 28 hospital systems and 16 countries. From
the analysis, an increase in stroke severity on
admission was observed. Additionally, the findings
suggested ischemic strokes are associated with a
higher mortality and more severe outcomes. 6
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